Lisbeth Bonde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisbeth Bonde has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Bent Ottesen
Department of Gynecology, Juliane Marie Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
3 shared publications- Filip Krag Knop
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
3 shared publications - Helga Gimbel
University of Southern Denmark, Odense, Denmark; Department of Obstetrics and Gynecology, Zealand University Hospital, Roskilde, Denmark
3 shared publications - Emil Loldrup Fosbøl
Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, Copenhagen 2100
2 shared publications - Gunnar Hilmar Gislason
Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte , Hospitalsvej 1, 2900 Hellerup
2 shared publications J. A. Svare
Department of Obstetrics and Gynaecology Herlev Hospital Coventry UK
2 shared publications
Latest Publications
- 1 September 2019
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 240, 144-150
Pelvic organ prolapse surgery after native tissue vault suspension at hysterectomy—A prospective cohort study
- 1 September 2019
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 240, 144-150
Pelvic organ prolapse surgery after native tissue vault suspension at hysterectomy—A prospective cohort study
- Open Access
- 1 June 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 225, 141-147
No evidence of association between native tissue vault suspension and risk of pelvic pain or sexual dysfunction
- 1 June 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 225, 141-147
Open AccessNo evidence of association between native tissue vault suspension and risk of pelvic pain or sexual dysfunction
- 20 December 2016
- Published by Springer Nature in International Urogynecology Journal
- Vol. 28 (7) , 1067-1075
Vaginal vault suspension during hysterectomy for benign indications: a prospective register study of agreement on terminology and surgical procedure
Introduction and hypothesis Several suspension methods are used to try to prevent pelvic organ prolapse (POP) after hysterectomy. We aimed to evaluate agreement on terminology and surgical procedure of these methods. Methods We randomly chose 532 medical records of women with a history of hysterectomy from the Danish Hysterectomy and Hysteroscopy Database (DHHD). Additionally, we video-recorded 36 randomly chosen hysterectomies. The hysterectomies were registered in the DHHD. The material was categorized according to predefined suspension methods. Agreement compared suspension codes in DHHD (gynecologists’ registrations) with medical records (gynecologists’ descriptions) and with videos (reviewers’ categorizations) respectively. Whether the vaginal vault was suspended (pooled suspension) or not (no suspension method + not described) was analyzed, in addition to each suspension method. Results Regarding medical records, agreement on terminology was good among patients undergoing pooled suspension in cases of hysterectomy via the abdominal and vaginal route (agreement 78.7, 92.3%). Regarding videos, agreement on surgical procedure was good among pooled suspension patients in cases of hysterectomy via the abdominal, laparoscopic, and vaginal routes (agreement 88.9, 97.8, 100%). Agreement on individual suspension methods differed regarding both medical records (agreement 0–90.1%) and videos (agreement 0–100%). Conclusions Agreement on terminology and surgical procedure regarding suspension method was good in respect of pooled suspension. However, disagreement was observed when individual suspension methods and operative details were scrutinized. Better consensus of terminology and surgical procedure is warranted to enable further research aimed at preventing POP among women undergoing hysterectomy.
- 20 December 2016
- Published by Springer Nature in International Urogynecology Journal
- Vol. 28 (7) , 1067-1075
Vaginal vault suspension during hysterectomy for benign indications: a prospective register study of agreement on terminology and surgical procedure
Introduction and hypothesis Several suspension methods are used to try to prevent pelvic organ prolapse (POP) after hysterectomy. We aimed to evaluate agreement on terminology and surgical procedure of these methods. Methods We randomly chose 532 medical records of women with a history of hysterectomy from the Danish Hysterectomy and Hysteroscopy Database (DHHD). Additionally, we video-recorded 36 randomly chosen hysterectomies. The hysterectomies were registered in the DHHD. The material was categorized according to predefined suspension methods. Agreement compared suspension codes in DHHD (gynecologists’ registrations) with medical records (gynecologists’ descriptions) and with videos (reviewers’ categorizations) respectively. Whether the vaginal vault was suspended (pooled suspension) or not (no suspension method + not described) was analyzed, in addition to each suspension method. Results Regarding medical records, agreement on terminology was good among patients undergoing pooled suspension in cases of hysterectomy via the abdominal and vaginal route (agreement 78.7, 92.3%). Regarding videos, agreement on surgical procedure was good among pooled suspension patients in cases of hysterectomy via the abdominal, laparoscopic, and vaginal routes (agreement 88.9, 97.8, 100%). Agreement on individual suspension methods differed regarding both medical records (agreement 0–90.1%) and videos (agreement 0–100%). Conclusions Agreement on terminology and surgical procedure regarding suspension method was good in respect of pooled suspension. However, disagreement was observed when individual suspension methods and operative details were scrutinized. Better consensus of terminology and surgical procedure is warranted to enable further research aimed at preventing POP among women undergoing hysterectomy.
- 1 November 2015
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 112, 68-72
Plasma YKL-40 during pregnancy and gestational diabetes mellitus
- 1 November 2015
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 112, 68-72
Plasma YKL-40 during pregnancy and gestational diabetes mellitus
- 1 April 2014
- Published by Wiley in Diabetic Medicine
- Vol. 31 (8) , 936-940
Decreased plasma chemerin levels in women with gestational diabetes mellitus
Aims: To evaluate fasting and post‐prandial serum chemerin levels in pregnant women with and without gestational diabetes, and again following delivery when normal glucose homeostasis is re‐established.Methods: Chemerin levels were measured in serum from nine women with gestational diabetes, and from eight age‐ and BMI‐matched pregnant women with normal glucose tolerance during two meal tests: in the third trimester and 3–4 months post partum. All women with gestational diabetes re‐established normal glucose tolerance after delivery.Results: Meal intake did not affect serum chemerin levels. The group with gestational diabetes had lower mean serum chemerin levels during the third trimester compared with the group with normal glucose tolerance (28 ± 1.3 vs. 88 ± 3.5 ng/ml, P < 0.0001). In the group with normal glucose tolerance, mean serum chemerin levels decreased significantly post partum to 57 ± 2.8 ng/ml (P = 0.0001), but remained significantly (P = 0.0003) higher than post‐partum levels in the group with gestational diabetes (31 ± 1.9 ng/ml), which did not differ significantly from third trimester levels (P = 0.31).Conclusions: Normal pregnancy is associated with increased circulating chemerin levels, which may act to reduce pregnancy‐induced insulin resistance and prevent glucose intolerance. Women with gestational diabetes, however, have severely reduced chemerin levels that remain low after delivery, which may contribute to the insulin resistance, glucose intolerance and high Type 2 diabetes risk associated with gestational diabetes.
- 1 April 2014
- Published by Wiley in Diabetic Medicine
- Vol. 31 (8) , 936-940
Decreased plasma chemerin levels in women with gestational diabetes mellitus
Aims: To evaluate fasting and post‐prandial serum chemerin levels in pregnant women with and without gestational diabetes, and again following delivery when normal glucose homeostasis is re‐established.Methods: Chemerin levels were measured in serum from nine women with gestational diabetes, and from eight age‐ and BMI‐matched pregnant women with normal glucose tolerance during two meal tests: in the third trimester and 3–4 months post partum. All women with gestational diabetes re‐established normal glucose tolerance after delivery.Results: Meal intake did not affect serum chemerin levels. The group with gestational diabetes had lower mean serum chemerin levels during the third trimester compared with the group with normal glucose tolerance (28 ± 1.3 vs. 88 ± 3.5 ng/ml, P < 0.0001). In the group with normal glucose tolerance, mean serum chemerin levels decreased significantly post partum to 57 ± 2.8 ng/ml (P = 0.0001), but remained significantly (P = 0.0003) higher than post‐partum levels in the group with gestational diabetes (31 ± 1.9 ng/ml), which did not differ significantly from third trimester levels (P = 0.31).Conclusions: Normal pregnancy is associated with increased circulating chemerin levels, which may act to reduce pregnancy‐induced insulin resistance and prevent glucose intolerance. Women with gestational diabetes, however, have severely reduced chemerin levels that remain low after delivery, which may contribute to the insulin resistance, glucose intolerance and high Type 2 diabetes risk associated with gestational diabetes.
- 13 February 2013
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 15 (8) , 713-720
Reduced postprandial GLP ‐1 responses in women with gestational diabetes mellitus
Aim: We investigated postprandial glucagon‐like peptide‐1 (GLP‐1) responses in pregnant women with and without gestational diabetes mellitus (GDM) and again following delivery when normal glucose tolerance (NGT) was re‐established. Methods: Eleven women with GDM [plasma glucose (PG) concentration at 120 min after a 75‐g oral glucose tolerance test (OGTT): 10.0 ± 0.9 mM (mean ± SD); age: 31 ± 6 years; body mass index (BMI): 31.6 ± 6.4 kg/m 2 ; haemoglobin A1c (HbA1c): 5.6 ± 0.5%] and eight pregnant women with NGT (PG 120min, OGTT : 5.7 ± 0.7 mM; age: 28 ± 3 years; BMI: 29.7 ± 5.4 kg/m 2 ; HbA1c: 5.4 ± 0.3%) were investigated with a 4‐h liquid meal test during third trimester (TT) and 3–4 months postpartum (PP). All patients with GDM re‐established NGT following delivery. Results: Pregnancy was associated with low postprandial GLP‐1 responses. Patients with GDM exhibited reduced postprandial GLP‐1 responses compared to their PP levels [area under curve (AUC): 5.5 ± 1.3 vs. 8.4 ± 3.2 nM × min, p =0.005], but the difference among NGT women (7.3 ± 2.8 vs. 8.8 ± 2.0 nM × min, p =0.066) was not statistically significant. Pregnancy did not influence postprandial responses of the other incretin hormone glucose‐dependent insulinotropic polypeptide (GIP) in any of the groups, but GDM patients were characterized by greater postprandial GIP responses during both TT and PP compared to NGT subjects. Conclusions: Pregnancy is associated with reduced postprandial GLP‐1 responses (most pronounced in patients with GDM) that normalize after delivery. In contrast, postprandial GIP responses seem unaffected by pregnancy but is increased in GDM patients.
- 13 February 2013
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 15 (8) , 713-720
Reduced postprandial GLP ‐1 responses in women with gestational diabetes mellitus
Aim: We investigated postprandial glucagon‐like peptide‐1 (GLP‐1) responses in pregnant women with and without gestational diabetes mellitus (GDM) and again following delivery when normal glucose tolerance (NGT) was re‐established. Methods: Eleven women with GDM [plasma glucose (PG) concentration at 120 min after a 75‐g oral glucose tolerance test (OGTT): 10.0 ± 0.9 mM (mean ± SD); age: 31 ± 6 years; body mass index (BMI): 31.6 ± 6.4 kg/m 2 ; haemoglobin A1c (HbA1c): 5.6 ± 0.5%] and eight pregnant women with NGT (PG 120min, OGTT : 5.7 ± 0.7 mM; age: 28 ± 3 years; BMI: 29.7 ± 5.4 kg/m 2 ; HbA1c: 5.4 ± 0.3%) were investigated with a 4‐h liquid meal test during third trimester (TT) and 3–4 months postpartum (PP). All patients with GDM re‐established NGT following delivery. Results: Pregnancy was associated with low postprandial GLP‐1 responses. Patients with GDM exhibited reduced postprandial GLP‐1 responses compared to their PP levels [area under curve (AUC): 5.5 ± 1.3 vs. 8.4 ± 3.2 nM × min, p =0.005], but the difference among NGT women (7.3 ± 2.8 vs. 8.8 ± 2.0 nM × min, p =0.066) was not statistically significant. Pregnancy did not influence postprandial responses of the other incretin hormone glucose‐dependent insulinotropic polypeptide (GIP) in any of the groups, but GDM patients were characterized by greater postprandial GIP responses during both TT and PP compared to NGT subjects. Conclusions: Pregnancy is associated with reduced postprandial GLP‐1 responses (most pronounced in patients with GDM) that normalize after delivery. In contrast, postprandial GIP responses seem unaffected by pregnancy but is increased in GDM patients.